Molecular Loop

Molecular Loop is an early-stage biotech company developing innovative solutions for targeted next-generation sequencing. Its core technology, LoopCap™, integrates target capture and library preparation into a simplified, scalable workflow designed to reduce complexity, time, and cost for research laboratories. The company is currently focused on the research-use-only market, with applications in inherited disease, infectious disease, and custom panel design, partnering with academic and commercial entities to validate and expand its technology's utility. Molecular Loop operates as a private, likely pre-revenue platform company seeking to establish its technology as a new standard in targeted sequencing workflows.

LoopCap™ technology: a single-tube chemistry that combines target capture and library preparation for next-generation sequencing using Molecular Inversion Probes (MIPs). It enables simple, fast, and highly uniform targeted sequencing workflows.

Molecular Loop competes in the targeted NGS enrichment market against giants like Illumina, Agilent, Thermo Fisher, and Roche, which offer hybrid-capture and amplicon-based solutions. Its differentiation lies in the simplicity and speed of its single-tube MIP-based workflow, but it must convince customers to switch from deeply entrenched, well-supported industry-standard platforms.